Tyme Technologies Inc
NASDAQ:TYME
Tyme Technologies Inc
Accrued Liabilities
Tyme Technologies Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tyme Technologies Inc
NASDAQ:TYME
|
Accrued Liabilities
$491.6k
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accrued Liabilities
$5.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Accrued Liabilities
$14.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
39%
|
CAGR 10-Years
28%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
28%
|
See Also
What is Tyme Technologies Inc's Accrued Liabilities?
Accrued Liabilities
491.6k
USD
Based on the financial report for Jun 30, 2022, Tyme Technologies Inc's Accrued Liabilities amounts to 491.6k USD.
What is Tyme Technologies Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
1%
Over the last year, the Accrued Liabilities growth was 20%. The average annual Accrued Liabilities growth rates for Tyme Technologies Inc have been 1% over the past three years .